Health Care Select Sector SPDR Fund
Price through Oct 27, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 27, 2026. Holdings snapshot retrieved Oct 27, 2026.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
XLV price
Table
| Date | XLV close |
|---|---|
| Jul 27, 2026 | $163.40 |
| Jul 28, 2026 | $167.26 |
| Jul 29, 2026 | $166.24 |
| Jul 30, 2026 | $163.52 |
| Jul 31, 2026 | $162.55 |
| Aug 3, 2026 | $162.24 |
| Aug 4, 2026 | $162.10 |
| Aug 5, 2026 | $164.16 |
| Aug 6, 2026 | $164.45 |
| Aug 7, 2026 | $165.68 |
| Aug 10, 2026 | $168.44 |
| Aug 11, 2026 | $168.01 |
| Aug 12, 2026 | $168.44 |
| Aug 13, 2026 | $168.38 |
| Aug 14, 2026 | $167.37 |
| Aug 17, 2026 | $167.05 |
| Aug 18, 2026 | $169.73 |
| Aug 19, 2026 | $175.68 |
| Aug 20, 2026 | $172.39 |
| Aug 21, 2026 | $174.62 |
| Aug 24, 2026 | $174.70 |
| Aug 25, 2026 | $175.29 |
| Aug 26, 2026 | $173.54 |
| Aug 27, 2026 | $171.58 |
| Aug 28, 2026 | $171.16 |
| Aug 31, 2026 | $170.54 |
| Sep 1, 2026 | $171.67 |
| Sep 2, 2026 | $172.95 |
| Sep 3, 2026 | $173.26 |
| Sep 4, 2026 | $171.45 |
| Sep 8, 2026 | $167.13 |
| Sep 9, 2026 | $166.58 |
| Sep 10, 2026 | $165.66 |
| Sep 11, 2026 | $165.36 |
| Sep 14, 2026 | $167.75 |
| Sep 15, 2026 | $167.66 |
| Sep 16, 2026 | $167.77 |
| Sep 17, 2026 | $168.81 |
| Sep 18, 2026 | $168.39 |
| Sep 21, 2026 | $169.01 |
| Sep 22, 2026 | $169.89 |
| Sep 23, 2026 | $168.80 |
| Sep 24, 2026 | $169.87 |
| Sep 25, 2026 | $170.70 |
| Sep 28, 2026 | $171.26 |
| Sep 29, 2026 | $170.73 |
| Sep 30, 2026 | $168.42 |
| Oct 1, 2026 | $166.20 |
| Oct 2, 2026 | $166.18 |
| Oct 5, 2026 | $167.37 |
| Oct 6, 2026 | $167.09 |
| Oct 7, 2026 | $168.81 |
| Oct 8, 2026 | $168.16 |
| Oct 9, 2026 | $170.81 |
| Oct 12, 2026 | $171.99 |
| Oct 13, 2026 | $169.66 |
| Oct 14, 2026 | $173.96 |
| Oct 15, 2026 | $177.19 |
| Oct 16, 2026 | $176.71 |
| Oct 19, 2026 | $175.65 |
| Oct 20, 2026 | $179.82 |
| Oct 21, 2026 | $178.94 |
| Oct 22, 2026 | $181.30 |
| Oct 23, 2026 | $179.28 |
| Oct 26, 2026 | $179.28 |
| Oct 27, 2026 | $179.18 |
Weekly net flows, 3M
Net outflow over the range: −$174M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Jul 27 | −$793.5M |
| Aug 3 | $711.3M |
| Aug 10 | $16.5M |
| Aug 17 | −$413.3M |
| Aug 24 | −$132.7M |
| Aug 31 | $234.3M |
| Sep 7 | $157.8M |
| Sep 14 | −$378.3M |
| Sep 21 | −$154.8M |
| Sep 28 | $84.2M |
| Oct 5 | $276.9M |
| Oct 12 | $370M |
| Oct 19 | $99.2M |
| Oct 26 | −$252M |
Money keeps arriving — +$578M of net inflows over the past month, about 1.2% of the fund's asset base, while the price has returned +15.7% so far this year. At 0.090% a year, no lower reported fee appears among the alternatives shown here.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 15.50% | $1281.91 | +0.2% | ||
| 2 | JNJJOHNSON & JOHNSON | 10.45% | $268.73 | +0.9% | ||
| 3 | ABBVABBVIE | 7.72% | $286.39 | -0.1% | ||
| 4 | UNHUNITEDHEALTH GROUP | 6.49% | $410.39 | -0.1% | ||
| 5 | MRKMERCK & CO | 5.44% | $141.82 | +0.9% | ||
| 6 | TMOTHERMO FISHER SCIENTIFIC | 3.64% | $693.02 | +1.2% | ||
| 7 | AMGNAMGEN | 3.55% | $447.95 | +0.7% | ||
| 8 | GILDGILEAD SCIENCES | 2.77% | $159.08 | +0.2% | ||
| 9 | ABTABBOTT LABORATORIES | 3.12% | $103.10 | -1.7% | ||
| 10 | PFEPFIZER | 2.41% | $29.80 | +0.0% | ||
| 11 | ISRGINTUITIVE SURGICAL | 2.12% | $445.88 | -1.3% | ||
| 12 | DHRDANAHER | 2.10% | $232.00 | -0.4% | ||
| 13 | VRTXVERTEX PHARMACEUTICALS | 2.07% | $521.03 | +0.7% | ||
| 14 | BMYBRISTOL MYERS SQUIBB | 2.25% | $61.55 | -0.1% | ||
| 15 | MDTMEDTRONIC | 1.87% | $93.95 | -0.9% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 64Sector weights
- Healthcare100%
- Health Technology76.26%
- Health Services17.05%
- Distribution Services4.53%
- Retail Trade1.77%
- Commercial Services0.25%
- Mutual fund0.14%
- Other0.09%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 76.26% |
| Health Services | 17.05% |
| Distribution Services | 4.53% |
| Retail Trade | 1.77% |
| Commercial Services | 0.25% |
| Mutual fund | 0.14% |
| Other | 0.09% |
Country weights
- United States100%
- Ireland2.5%
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 2.5% |
| 1 week | +0.1% |
| 1 month | +5.0% |
| 3 months | +9.7% |
| 6 months | +24.3% |
| YTD | +15.7% |
| 1 year | +22.4% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | −$714M |
| 1 month | +$578M |
| 3 months | −$174M |
| YTD | +$794M |
| 1 year | +$1.4B |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Nov | $931.4M |
| Dec | −$395.2M |
| Jan | $1.3B |
| Feb | $677.6M |
| Mar | −$908M |
| Apr | −$536.3M |
| May | −$549.5M |
| Jun | $24M |
| Jul | $165.5M |
| Aug | $79.8M |
| Sep | $54M |
| Oct | $485.2M |
The top holding is 15.5% of the book; the top ten carry 61%. Spread across 60+ names, it behaves like roughly 17 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $52M | $53M |
| AMGN AMGEN | $64M | $2M |
| LLY ELI LILLY | $24M | $26M |
| UNH UNITEDHEALTH GROUP | $13M | $13M |
| MCK MCKESSON | $6M | $5M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat XLV on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $40.7B | +$609M | -6bp on fee · +$609M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -6bp on fee · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -5bp on fee · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$51M | -5bp on fee · +$51M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -5bp on fee · +$412M in over the month | Head-to-head |